4cgo
From Proteopedia
(Difference between revisions)
m (Protected "4cgo" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4cgo is ON HOLD | + | The entry 4cgo is ON HOLD until Paper Publication |
Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J. | Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J. | ||
Description: Leishmania major N-myristoyltransferase in complex with a thienopyrimidine inhibitor | Description: Leishmania major N-myristoyltransferase in complex with a thienopyrimidine inhibitor | ||
Revision as of 08:49, 18 December 2013
Unreleased structure
The entry 4cgo is ON HOLD until Paper Publication
Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J.
Description: Leishmania major N-myristoyltransferase in complex with a thienopyrimidine inhibitor
